-
DEVELOPMENT OF AN ALGERIA-SPECIFIC MULTI-CRITERIA DECISION ANALYSIS FRAMEWORK FOR THE EVALUATION OF RARE DISEASE MEDICINES
Aug 11, 2026, 17:15 PM -
OVERVIEW OF DECISION MAKING PROCESS AND APPRAISAL OF NEW MEDICAL DEVICE COVERAGE IN HUNGARY
Aug 11, 2026, 17:15 PM -
MODERN EXCEL FOR COST-EFFECTIVENESS MODELING: EFFICIENCY GAINS, VALIDATION CHALLENGES, AND HTA ACCEPTABILITY
Aug 11, 2026, 17:15 PM -
WILL EU JOINT CLINICAL ASSESSMENT (JCA) REDUCE "ADDITIONAL BENEFIT NOT PROVEN" OUTCOMES IN GERMANY? EVIDENCE FROM RECENT G-BA DECISIONS SUGGESTS PERSISTENT, AVOIDABLE GAPS
Aug 11, 2026, 17:15 PM -
REAL-WORLD CLINICAL, SAFETY AND ECONOMIC OUTCOMES OF ACORAMIDIS UNDER AN EARLY ACCESS PROGRAM: A PHARMACIST-LED EVALUATION FROM A PORTUGUESE NHS REFERENCE CENTRE
Aug 11, 2026, 17:15 PM -
INCREMENTAL RETURN ON INVESTMENT OF EXPANDING CANCER BIOBANK FUNDING: A PROSPECTIVE ANALYSIS FROM CHILE
Aug 11, 2026, 17:15 PM -
ECONOMIC EVALUATION OF WOLBACHIA PROGRAMS FOR DENGUE CONTROL: A SYSTEMATIC REVIEW
Aug 11, 2026, 17:15 PM -
TIME TO REIMBURSEMENT OF NEW MEDICINES IN IRELAND-BENCHMARKING PROGRESS BEFORE IMPLEMENTATION OF THE 2026 FRAMEWORK AGREEMENT
Aug 11, 2026, 17:15 PM -
EVALUATING THE COST-EFFECTIVENESS OF BARIATRIC SURGERY, INCRETIN-BASED THERAPY, AND LIFESTYLE MODIFICATION FOR OBESITY IN OMAN
Aug 11, 2026, 17:15 PM -
CONVERGENT BUT NOT EQUIVALENT: NATIONAL HTA EVIDENTIARY FLEXIBILITY AND RESIDUAL EVIDENCE ADAPTATION UNDER JOINT CLINICAL ASSESSMENT
Aug 11, 2026, 17:15 PM -
CHARACTERIZING THE MULTI-DIMENSIONAL BURDEN OF DISEASE AND GAPS IN SUPPORT AMONG PEOPLE WITH OBESITY UTILISING GLP-1 RECEPTOR AGONISTS
Aug 11, 2026, 17:15 PM -
THE FUTURE OF AI-ENABLED HEALTH TECHNOLOGY ASSESSMENT
Aug 11, 2026, 17:15 PM -
ASSOCIATION BETWEEN BODY MASS INDEX, OBSTRUCTIVE SLEEP APNEA, AND FATTY LIVER DISEASE: A MEDIATION AND MODERATION ANALYSIS IN AN OBSTRUCTIVE SLEEP APNEA SCREENING COHORT
Aug 11, 2026, 17:15 PM -
CLINICAL AND ECONOMIC IMPACT OF 20% WEIGHT REDUCTION IN MILITARY HEALTHCARE INSTITUTIONS IN THE KINGDOM OF SAUDI ARABIA USING THE VALUE OF WEIGHT LOSS SIMULATION MODEL
Aug 11, 2026, 17:15 PM -
COST-CONSEQUENCE ANALYSIS OF COVERED BALLOON-EXPANDABLE STENTS USING EXTRAPOLATED 3-YEAR OUTCOMES FOR AORTOILIAC OCCLUSIVE DISEASE IN THE UK
Aug 11, 2026, 17:15 PM -
MODELING THE DETERMINANTS OF INDIVIDUAL MEDICAL EXPENDITURES AN ECONOMETRIC AND MACHINE LEARNING ANALYSIS OF THE ROLE OF AGE OBESITY AND SMOKING
Aug 11, 2026, 17:15 PM -
CANCER BURDEN ATTRIBUTABLE TO MODIFIABLE RISK FACTORS IN HUNGARY: INCORPORATING THE HUN-CANCER EPIDEMIOLOGICAL DATABASE INTO GLOBAL FRAMEWORKS
Aug 11, 2026, 17:15 PM -
DISTRIBUTION OF INCREMENTAL QALY ESTIMATES REPORTED IN HTA CONCLUSIONS IN UKRAINE (2022-2026)
Aug 11, 2026, 17:15 PM -
ECONOMIC IMPACT OF ORAL CORTICOSTEROID-RELATED COMORBIDITIES IN PATIENTS WITH ACETYLCHOLINE RECEPTOR ANTIBODY-POSITIVE (ACHR-AB+) GENERALISED MYASTHENIA GRAVIS (GMG) IN THE UNITED STATES (US)
Aug 11, 2026, 17:15 PM -
MLUMR: AN R PACKAGE FOR POPULATION-ADJUSTED INDIRECT COMPARISONS USING MULTILEVEL UNANCHORED META-REGRESSION
Aug 11, 2026, 17:15 PM
